Skip to content
Search

Latest Stories

NHS booster booking opens for 12-15 year-olds

The NHS booster bookings is now open for 12 to 15 year-olds, who are most at risk from COVID, including those who are severely immuno-suppressed and with underlying health conditions.

The national booking service has been updated so that the most vulnerable in this cohort can quickly and easily book in a booster jab when they become eligible.


GP-led teams and consultants continue to work to identify household contacts of severely immuno-suppressed people to book them in for their jab. Some 6,400 invitations have already been sent to parents and guardians of eligible children inviting them to get vaccinated by a local GP-led team.

The NHS will also be writing out shortly to the 4,400 currently eligible to invite them to book in using the national booking service.

Nikki Kanani, GP and Deputy SRO for the NHS COVID Vaccination Programme, said: “Children’s lives, including their education, have been significantly disrupted over the last two years and every parent wants to do all they can to protect their little ones and keep them in school.

“But when a family has the added worry of what COVID could mean for a child who is seriously unwell, getting them their top up boost in protection as soon as they become eligible is vitally important.

“For young people aged 12 to 15 who are clinically at risk that is a booster three months after their second dose, with it now even easier for families to get their child booked in and protected at a convenient vaccination centre nearby.”

So far, the vaccination drive has delivered almost 32 million boosters to more than four in five eligible adults over 800,000 young people aged 12 to 15s have had a second jab in total.

The NHS has pulled out all the stops to make vaccinations as easy as possible for kids, including therapy dog Ruby helping ease any nerves in Nottingham and a mini-toy town in the Black Country with kids getting to play hop-scotch, a treasure hunt, and snake and ladders following vaccination.

School led-vaccination teams led on the initial rollout of first and second jabs to the cohort, and while schools continue to vaccinate, eligible 12-15 year old can also book in their first and second jabs using the national booking service.

Clinically at-risk 12 to 15 year old or those who live with someone who is immuno-suppressed are entitled to their booster three months after their two primary doses, with those who are severely immuno-suppressed able to get their booster after a third primary dose.

In total, there are around 55,000 young people who are immuno-suppressed and the additional option to book online makes it even easier for families to get their child booked in so they can get protected at an existing and convenient vaccination centre.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less